Delivery Order SPE2DB22D1202-SPE2DB24FURB3
Award Date 2/20/24
Potential Completion Date 2/21/24
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,526.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a completion date of February 23, 2024 and does not utilize any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
- Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a $3,851.78 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of PEDIARIX 0.5 ML SYRINGE 0.5ML. This delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $1,526.44 by the Defense Logistics Agency (DLA) to provide PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, supplying a range of pharmaceuticals and medical supplies in support of military treatment programs and...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical worth $1,156.26. The contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, with a completion date of February 15, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to $999,999,999.00 through...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, valued at $13,941.50. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,912.32, has a completion date of June 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. The total potential value of this order is $3,210.65, with a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $11,280.99 firm fixed-price delivery order is for PEDIARIX 0.5 ML SYRINGE 0.5ML medical supplies. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide PEDIARIX 0.5ML syringes. The $15,902.20 delivery order has a completion date of February 6, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceuticals and medical supplies to U.S. government agencies, including the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical products. The $3,052.95 Firm Fixed Price delivery order was awarded on April 16, 2024 by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 17, 2024. This contract does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a significant...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FURB3Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,159.23 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a completion date of February 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 5/21/24, 10:05 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 2/20/24 |